동일날짜 처방전 2매 이상인 외래 소아환자 의약품처방의 적정성에 대한 후향적 평가Retrospective Drug Utilization Review on Prescriptions for Outpatient Pediatrics Patients having 2 or more Same-day Prescriptions
- Other Titles
- Retrospective Drug Utilization Review on Prescriptions for Outpatient Pediatrics Patients having 2 or more Same-day Prescriptions
- Authors
- 남궁보라; 손현순; 신현택
- Issue Date
- Mar-2012
- Publisher
- 한국임상약학회
- Keywords
- drug utilization review; DUR criteria; pediatrics; outpatient; claims data
- Citation
- 한국임상약학회지, v.22, no.1, pp 73 - 80
- Pages
- 8
- Journal Title
- 한국임상약학회지
- Volume
- 22
- Number
- 1
- Start Page
- 73
- End Page
- 80
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/12288
- ISSN
- 1226-6051
- Abstract
- This study was to describe inappropriate drug use in outpatient pediatrics who having 2 or more same-day prescriptions.
Retrospective drug utilization reviews(DURs) were implemented to samples from national health insurance claims data during December 2008 to February 2009 nationwide, using 5 DUR criteria(duplication, drug-drug interaction, drugdisease interaction, drug-age contraindication, incorrect dosage) established in the Drug Information Framework(DIF)-Korea™ DUR program. Among 38,451 claims analyzed in the study, 74.7% had one or more conflicts in the 5 DUR modules. Among 16,472 patients analyzed, 49.6% had conflicts with duplication criteria composing ingredient duplication(23.3%) and therapeutic class duplication(39.6%). Incorrect dosages were found in 73.6% of patients and under-dosage conflict accounted for 59.9% which is higher than over-dosage conflict(38.3%). In this study, inappropriate drug prescriptions such as under-dose, pediatric contraindication and therapeutic duplication were prevalent in pediatrics outpatient setting, suggesting much more awareness in a societal perspective, to prevent drug related problems in a vulnerable pediatric group.
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.